SPRING, Texas, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today presentation at the San Antonio Breast Cancer Symposium, in San Antonio, TX; of data ...
Read MoreADELAIDE, Australia, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Avance Clinical, the award-winning global CRO for biotechs, has announced the launch of its new Diversity in STEM Scholarships , a global initiative designed to support women and ...
Read MoreNew Website: https://gcls.ai GENEVA, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The Geneva College of Longevity Science (GCLS) , in partnership with DrVibe.ai , today announced the launch of the GCLS AI Academy for Longevity Sciences —the ...
Read MoreEXECUTIVE SUMMARY VALLAURIX Research, Development & Innovation Centre to expand its existing facilities and capabilities core focus on accelerating development of liquid long-acting drug delivery platforms existing RD&I teams will advance ...
Read MorePR Newswire LONDON and NEW HAVEN, Conn., Dec. 11, 2025 LONDON and NEW HAVEN, Conn., Dec. 11, 2025 /PRNewswire/ -- Biohaven Ltd. (NYSE: BHVN) announced today that it presented clinical safety and efficacy data for BHV-1510 at the 2025 ...
Read MorePR Newswire INDIANAPOLIS, Dec. 11, 2025 In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost an average of 28.7% of their body weight at 68 weeks Retatrutide reduced WOMAC pain scores by up to an ...
Read MorePR Newswire SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 SOUTH SAN FRANCISCO, Calif., Dec. 11, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced it has completed its ...
Read MorePR Newswire TEMPE, Ariz., Dec. 11, 2025 Urgent: New Wellness Initiative Combats Record Burnout & PTSD in Police and Fire Departments. ReGen Total Wellness, an Arizona-based performance and recovery brand, has expanded its partnership with ...
Read MorePR Newswire PHOENIX, Dec. 11, 2025 PHOENIX, Dec. 11, 2025 /PRNewswire/ -- With periodontal disease affecting more than four in ten American adults and growing evidence connecting oral bacteria to conditions such as cardiovascular disease, ...
Read MorePR Newswire HONG KONG, Dec. 10, 2025 HONG KONG, Dec. 10, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ...
Read MorePR Newswire TOKYO, Dec. 10, 2025 - Data reflect new insights and precision oncology advancements in portfolio and pipeline - - Cohort results from Phase 2 ILUSTRO study evaluating a zolbetuximab triplet combination regimen in first-line ...
Read MorePR Newswire TAIPEI and SAN DIEGO, Dec. 10, 2025 TAIPEI and SAN DIEGO, Dec. 10, 2025 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company developing first-in-class therapies for difficult-to-treat ...
Read MorePR Newswire PHILADELPHIA and IRVING, Texas, Dec. 10, 2025 New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence ...
Read MorePR Newswire LAS VEGAS, Dec. 10, 2025 The total pancreatic cancer market size is expected to increase in the 7MM during the forecast period, driven by ongoing clinical research and the development of better diagnostic tools, which may improve ...
Read MorePR Newswire SCHAUMBURG, Ill., Dec. 10, 2025 SCHAUMBURG, Ill., Dec. 10, 2025 /PRNewswire/ -- The holidays can be a magical time, but they can also present hidden pet hazards and difficult decisions for pet owners and gift-givers. The American ...
Read MorePR Newswire BOSTON, Mass., Dec. 10, 2025 Key Highlights: BOSTON, Mass., Dec. 10, 2025 /PRNewswire/ -- Privo Technologies, Inc., today announced that the first patient has been dosed in its first-in-human clinical trial evaluating PRV131, ...
Read MorePR Newswire UNION, N.J., Dec. 10, 2025 "A Legacy of Impact – A Future of Recovery" Will Revitalize Elizabeth Facility UNION, N.J., Dec. 10, 2025 /PRNewswire/ -- Bridgeway Behavioral Health Services has officially launched a $2 million ...
Read MorePR Newswire NEW YORK, Dec. 10, 2025 NEW YORK, Dec. 10, 2025 /PRNewswire/ -- Breast cancer remains one of the most common cancers in the world — but advances in screening, diagnostic tools, and personalized treatment are transforming how ...
Read More
MEDINDIA
English
हिन्दी
Español
français
中文